July 18, 2023 Comments Off on New patent for Pharmacyclics Inc drug IMBRUVICA Posted in: Patent Added Annual Drug Patent Expirations for IMBRUVICA Imbruvica is a drug marketed by Pharmacyclics Inc and is included in three NDAs. It is available from one supplier. There are fifty-five patents…
The post New patent for Pharmacyclics Inc drug IMBRUVICA appe…
July 18, 2023 Comments Off on New patent for Acelrx Pharms drug DSUVIA Posted in: Patent Added Annual Drug Patent Expirations for DSUVIA Dsuvia is a drug marketed by Acelrx Pharms and is included in one NDA. It is available from one supplier. There are eighteen patents…
The post New patent for Acelrx Pharms drug DSUVIA appeared first on DrugPate…